Bladder
Dysfunction and MS
Multiple sclerosis (MS)
involves focal neural demyelination with relative sparing of axons
and resultant impaired nerve conduction. Demyelination commonly
affects the posterolateral columns of the spinal cord, with the
majority of patients having cervical cord involvement. Forty percent
of patients have lumbar cord involvement and 18 percent have sacral
cord involvement. The cerebral cortex and midbrain may also be
affected. Lesions in any of these areas can affect voiding function.
Fifty percent to 90 percent of all
MS patients will experience bladder dysfunction during the course of
the disease, and voiding dysfunction is the presenting symptom in 10
percent of patients. Therefore, it is imperative that one consider
MS in the differential diagnosis of patients with significant
voiding complaints.
BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS PATIENTS
The incidence of bladder
dysfunction in MS patients is shown in the TABLE below.
Urinary incontinence related to neurogenic bladder dysfunction is
caused by one of three problems: (1) failure to store, (2) failure
to empty, or (3) a combination of the two. It is important to rule
out urinary tract infection and other nonneurogenic causes,
particularly in multiparous women who may have gynecologic causes
for incontinence.
Abnormality |
Incidence |
| Type: |
Range
/ (avg.) |
| Detrusor
hyperreflexia, shpincter synergia: |
26%-50% /
38% |
| Detrusor
hyperreflexia, shpincter dyssynergia: |
24%-46% /
29% |
| Arreflexia: |
19%-40% /
26% |
Treatment
Options
The goals of treatment are to
restore continence, relieve urinary symptoms, reverse or stabilize
upper urinary tract changes if they are present, and facilitate
complete bladder emptying. To accomplish this, a common strategy is
to create complete urinary retention and add clean intermittent
catheterization for emptying. The
course of MS is unpredictable often involving exacerbations and
remissions. Therefore, treatment should be as flexible and
conservative as possible, with the option for modification based on
repeat urodynamic studies if it becomes necessary. Additionally, the
clinician should be aware that the lower urinary tract symptoms do
not necessarily correlate with the pathophysiology of the bladder
dysfunction. Therapeutic options for bladder dysfunction in MS
patients are divided into no surgical and surgical treatment.
MS Incontinence
Treated Properly
Patients with MS and bladder
dysfunction often present with a broad range of voiding symptoms.
Once the diagnosis of MS is confirmed, a patient's urine should be
sent for culture. If the culture is positive, the patient should be
treated with appropriate antibiotics based on the sensitivity of the
organism(s).
Once the urine is
free of infection, or if the initial urine culture is negative, all
MS patients should have a post-void residual (PVR) checked either by
in-and-out catheterization or ultrasound of the bladder (bladder
scan). Referral to a urologist is indicated if the urinary tract
infection cannot be cleared or there is no relief of the initial
symptoms despite a clean urine culture.
|